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Abstract
Background: Dissecting the role copy number variants (CNVs) play in disease pathogenesis is directly reliant on
accurate methods for quantification. The Shar-Pei dog breed is predisposed to a complex autoinflammatory disease
with numerous clinical manifestations. One such sign, recurrent fever, was previously shown to be significantly
associated with a novel, but unstable CNV (CNV_16.1). Droplet digital PCR (ddPCR) offers a new mechanism for CNV
detection via absolute quantification with the promise of added precision and reliability. The aim of this study was
to evaluate ddPCR in relation to quantitative PCR (qPCR) and to assess the suitability of the favoured method as a
genetic test for Shar-Pei Autoinflammatory Disease (SPAID).
Results: One hundred and ninety-six individuals were assayed using both PCR methods at two CNV positions
(CNV_14.3 and CNV_16.1). The digital method revealed a striking result. The CNVs did not follow a continuum
of alleles as previously reported, rather the alleles were stable and pedigree analysis showed they adhered to
Mendelian segregation. Subsequent analysis of ddPCR case/control data confirmed that both CNVs remained
significantly associated with the subphenotype of fever, but also to the encompassing SPAID complex (p < 0.001). In
addition, harbouring CNV_16.1 allele five (CNV_16.1|5) resulted in a four-fold increase in the odds for SPAID (p < 0.001).
The inclusion of a genetic marker for CNV_16.1 in a genome-wide association test revealed that this variant explained
9.7 % of genetic variance and 25.8 % of the additive genetic heritability of this autoinflammatory disease.
Conclusions: This data shows the utility of the ddPCR method to resolve cryptic copy number inheritance patterns
and so open avenues of genetic testing. In its current form, the ddPCR test presented here could be used in canine
breeding to reduce the number of homozygote CNV_16.1|5 individuals and thereby to reduce the prevalence of
disease in this breed.
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Background
The role copy number variants (CNVs) play in genomic
processes spanning from evolution [1–4], through popu-
lation genetic diversity [5–8] and disease susceptibility
[9, 10] is under constant investigation. Whilst CNVs are
less common than single nucleotide polymorphisms
(SNPs), these genomic gains and losses are more likely
to have an impact on phenotypic diversity [9]. One of
the key mechanisms of action for CNVs is through the
disruption of gene or regulatory element dosage, leading
to perturbed gene expression. In order to dissect the im-
pact these structural variants play, it is essential that
they be accurately detected and quantified. Methods
such as fluorescence in situ hybridisation (FISH), multi-
plex ligation-dependent probe amplification (MLPA) and
array comparative genomic hybridisation (aCGH) can all
be used to detect copy number variants, but the estab-
lishment of mode of transmission or genotype may fall
to alternate PCR based methods such as quantitative* Correspondence: jennifer.meadows@imbim.uu.se2Department of Medical Biochemistry and Microbiology, Science for Life
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PCR (qPCR), or more recently, droplet digital PCR
(ddPCR).
The detection of canine CNVs has advanced dramatic-
ally from the first array CGH which revealed 155 vari-
ants [11], through to a catalogue of more than 1,600
polymorphisms which have been assayed in both domes-
tic dogs and a variety of members from the Canidae
family [5–8]. Through these studies and others (sum-
marised in [12]), we have gained insight into what sets
domestic dogs apart from their wild ancestors (e.g. a
CNV gain in a region encompassing AMY2B drives
increased amylase activity and the ability for domestic
animals to digest a starch rich diet [1]) and an under-
standing of dog phenotypic diversity and disease suscep-
tibility (e.g. a copy number gain encompassing FGF3,
FGF4 and FGF19 which results in the breed defining
dorsal ridge of the Rhodesian and Thai Ridgeback, but
also predisposes these breeds to dermoid sinus [13]).
The link between genotype and phenotype relies not
only on the ability to identify CNVs, but also on the ac-
curacy of variant quantification. If the CNV is to be used
diagnostically, the importance of the latter cannot be
overestimated.
This study focuses on two breed specific CNVs found
in the Chinese Shar-Pei; the “traditional” (14.3 kb) vari-
ant and the “meatmouth” (16.1 kb) variant, located in an
overlapping region of chromosome 13 [14]. It has been
reported that a high copy number of the 16.1 kb variant
is associated with the increased expression of Hyaluro-
nan Synthase 2 (HAS2), the driver of long-chain hyalur-
onan (HA) synthesis [14, 15]. The elevated expression of
HAS2 results in cutaneous hyaluronosis, creating the
Shar-Pei’s distinctive thickened and folded skin [16–18].
The increased copy number of the 16.1 kb variant was
also shown to be significantly correlated to the occur-
rence of a breed specific fever syndrome [14]. It was
hypothesised that the recurring fever followed the cyc-
lical over production and subsequent degradation of HA
and that low molecular weight HA was acting as a dan-
ger associated molecular pattern (DAMP) triggering the
release of inflammatory interleukins [14, 19].
More recently it was reported that this fever syndrome
was actually one of a spectrum of clinical signs including
arthritis, ear (otitis) and skin (vesicular hyaluronosis) in-
flammation and amyloidosis that were encompassed by
the larger Shar-Pei Autoinflammatory Disease (SPAID)
[20]. In a genetic study which utilised 250 carefully phe-
notyped individuals, genome wide association analyses
showed that the five clinical signs of SPAID overlapped
one genetic locus; a region which also encompassed
HAS2 and both the 14.3 kb and the 16.1 kb copy num-
ber variants [20].
When the 14.3 kb and the 16.1 kb CNVs were first
measured, the methodology employed was quantitative
PCR (qPCR) [14]. This was a primer-limited multiplex
qPCR where the result of an unknown individual was
calibrated to the result of an individual with known dip-
loid copy number (i.e. CNV = 2). The error in this meas-
urement was therefore a composite of the errors from
four PCR reactions (two individuals for both a target
CNV and reference PCR) and quadruplet replications.
When applied to the 16.1 kb variant this resulted in a
continuum of copy number estimates, from two to fif-
teen or more [14]. An alternative to qPCR is droplet
digital PCR (ddPCR). In the latter case, restriction
digested DNA and a multiplex PCR mix are evenly parti-
tioned across many thousands of oil droplets. After the
completion of thermocycling, the initial concentration of
template DNA is determined from the Poisson distribu-
tion of positive (those containing amplified target, be it
CNV or reference) and negative (those containing no
amplified target) reaction droplets [21]. Results compar-
ing the two PCR methodologies have generally shown
gains in precision and reproducibility when using ddPCR
versus qPCR [22–24] although, as noted by others, this
can come at an increased cost per reaction [25].
With the recent advancement in defining Shar-Pei
Autoinflammatory Disease and the availability of alter-
nate methods of quantifying copy number variants, the
aims of the current study were three-fold, i) to identify a
reliable CNV measurement method (quantitative PCR
versus droplet digital PCR), ii) to apply that method to
investigate the relationship between CNV load, the oc-
currence of SPAID and SPAID sub-phenotypes and iii)
to assess the utility of CNV variants as a genetic test for
SPAID.
Results
Droplet digital PCR has reduced variability compared to
quantitative PCR
Copy numbers were measured for 196 Shar-Pei
(Additional file 1: Table S1) with three assays (Assay-
CNV-East, Assay-CNV-759 and Assay-CNV-E, Fig. 1a)
and two methodologies, droplet digital PCR (ddPCR)
and quantitative PCR (qPCR). The relationship between
assays and methodologies is illustrated in Fig. 1. The lin-
ear correlation between methodologies was found to be
the highest for CNV-East (r2 = 0.72, Fig. 1b), followed by
CNV-759 (r2 = 0.64) and was the lowest for CNV-E
(r2 = 0.44). The value for CNV_14.3 as measured by
Assay-CNV-East was on average 0.14 CNVs smaller when
measured by ddPCR than qPCR. For CNV_16.1 the pat-
tern was discordant with CNV measures on average 3.44
and 0.77 larger (Assay-CNV-759 and Assay-CNV-E re-
spectively), when measured with ddPCR compared to
qPCR. Whilst qPCR CNV measures for one individual
were not always in agreement between Assay-CNV-759
and Assay-CNV-E (Average CNV difference = 2.66 ± 2.60),
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they were in extremely close agreement when measured
with ddPCR (Average CNV difference = 0.01 ± 0.52). Exam-
ples of these inconsistencies in qPCR compared to ddPCR
at an individual level are illustrated in Additional file 2:
Figure S1. From this point forward, the results of
Assay-CNV-759 and Assay-CNV-E will be presented
as the result for CNV_16.1, as the former were
interchangeable.
Breed specific CNVs are stable and inherited in a bi-allelic
fashion
ddPCR showed clearly that the results for both CNV_14.3
and CNV_16.1 formed three clusters (CNV_14.3: 2, 4, 6;
CNV_16.1: 2, 6, 10) suggesting that these copy number
variants may be acting as stably inherited alleles. We
tested this hypothesis in extended pedigrees (n = 92, Fig. 2;
Additional file 1: Table S1; Additional file 2: Figure S2)
Fig. 1 a The genomic location of the two CNVs and b the comparison of results obtained using quantitative PCR (qPCR) and droplet digital PCR
(ddPCR) for assays in each (CNV_14.3: Assay-CNV-East; CNV_16.1: Assay-CNV-759 and Assay-CNV-E). Regression analysis showed Assay-CNV-East
reported reasonably similar results (r2 = 0.72), whilst concordance was lower for Assay-CNV-759 (r2 = 0.64) and Assay-CNV-E (r2 = 0.44). In each assay
it can be seen ddPCR reports tighter clustering at higher qPCR values
Fig. 2 An example pedigree illustrates the segregation of CNV alleles across generations. The second generation shows a distribution that
is in keeping with Mendelian segregation. CNV results are coded to reflect the number of alleles per chromosome. Using the male in
generation one as an example, the result for CNV_14.3 (copy number: 4; alleles: 1|3) is written above that for CNV_16.1 (copy number: 6;
alleles: 5|1)
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and found that this was in fact true. CNV_14.3 was dem-
onstrated to have two alleles comprising either 1 or 3
copies and for CNV_16.1, alleles of 1 or 5 copies were
shown. For the full set of individuals included in the study
(n = 327), no alternate combinations were observed.
A pattern of CNV genotype segregation was observed
whereby CNV_14.3 = 2/CNV_16.1 = 10 accounted for
64.5 % of the CNV pairs, followed by CNV_14.3 = 4/
CNV_16.1 = 6 (30.3 %) and CNV_14.3 = 6/CNV_16.1 = 2
(4.3 %). However we also recorded the following pairs,
CNV_14.3 = 4/CNV_16.1 = 2 (0.6 %) and CNV_14.3 = 2/
CNV_16.1 = 6 (0.03 %).
CNV_16.1 is associated with increased HAS2 expression
and SPAID risk
Olsson et al., [14] showed that the expression of genes
HAS2 and HASas increased with increasing CNV_16.1
copy number. This experiment was replicated using their
gene expression measures and new ddPCR calculations
of copy number for the assayed fibroblast DNA. The
same trend of increased gene expression with CNV_16.1
copy number was observed (Additional file 2: Figure S3).
The ddPCR method provided the resolution required
to demonstrate that both duplications were stably trans-
mitted. In order to assess disease correlation, phenotype
positive and negative genotype and allele counts were
made (Table 1), and 2x2 allele risk- and odds- ratio cal-
culations performed (Table 2). As reported above, 64.5 %
of duplication pairs form the pattern of CNV_16.1 = 10/
CNV_14.3 = 2. This was patterned carried forward to
Table 1, where a high proportion both CNV_16.1 = 10 and
CNV_14.3 = 2 were recorded in affected individuals in
each disease set. It was shown previously that CNV_14.3
and CNV_16.1 are breed specific variants, and that a copy
number of two is observed at both genomic locations in
all other breeds [14]. We therefore assessed the link be-
tween CNV_16.1 and disease, and not CNV_14.3.
As reported in Table 1, the CNV_16.1 allele 5
(CNV_16.1|5) is the variant highly significantly associ-
ated to SPAID (p < 0.0001), and confered a greater than
four fold increase in odds-ratio (Table 2). Similar odds
ratios were noted for four of the five phenotypes of
SPAID, but not for Amyloidosis.
CNV_16.1 is predictive of disease risk
The utility of CNV_16.1 and CNV_14.3 in a genetic test
for SPAID was evaluated using random forest (RF) [26]
and J48 decision trees [27]. Given the low membership
of C1 (n = 34), a comparison with C2 (n = 80) was also
calculated. The best model was generated using the data
set containing the allelic information from both CNVs and
the maximum number of participants (C2 RF AUC=
0.613, Table 3), although the performance of all models
compared using the C2 control group were similar (max-
imum AUC difference 0.014).
Local genomic architecture may explain lower than
expected AUC
In the genome wide association analysis (GWAS) of
SPAID, Olsson et al. [20] noted high linkage disequilib-
rium (LD, r2 > 0.8) across the genomic regions associated
with all five SPAID sub-phenotypes. A GWAS was re-
peated with the addition of CNV_16.1 as a biallelic marker
to the genome wide set. With our reduced cohort (SPAID,
n = 155; C1, n = 34) and the same methodology as reported
previously [20], we found that whilst not reaching genome-
wide significance (λ = 1.04; pCNV_16.1 = 2.78 × 10
-5;
pBonferroni = 4.55 × 10
-7), the CNV marker explained
Table 1 Genotype and allele counts for the age limited SPAID cohort and each subphenotype thereina
SPAIDb Fever Arthritis Vesicular Hyaluronosis Otitis Amyloidosisc
+ - + - + - + - + - + -
Genotype
CNV_14.3 2 128 15 93 30 62 28 35 36 31 43 28 13
4 24 17 20 19 17 15 9 19 2 25 2 4
6 3 2 1 2 0 3 0 3 1 3 1 0
CNV_16.1 2 3 3 1 3 0 4 0 4 1 4 1 0
6 25 16 21 18 17 15 9 19 2 25 3 4
10 127 15 92 30 62 27 35 35 31 42 27 13
Allele
CNV_14.3 1 280 47 206 79 141 71 79 91 64 111 58 30
3 30 21 22 23 17 21 9 25 4 31 4 4
CNV_16.1 1 31 22 23 24 17 23 9 27 4 33 5 4
5 279 46 205 78 141 69 79 89 64 109 57 30
aThe proportion of each cohort (affected/unaffected) was, SPAID (155/34), Fever (114/51), Arthritis (79/46), Vesicular Hyaluronosis (44/58), Otitis (34/71). bSPAID
negative is equivalent to C1. cAmyloidosis (31/17) is not age limited, rather a negative result was determined by post-mortem histopathology
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approximately 10 % of the genetic variance (CNV_16.1 =
9.7 %) and close to 25 % of the genetic heritability
(CNV_16.1 = 25.8 %).
Discussion
We assessed the ability of two PCR methods, quantita-
tive PCR (qPCR) and droplet digital PCR (ddPCR), to
accurately quantify two breed specific CNVs in relation
to the susceptibility of Shar-Pei Autoinflammatory Dis-
ease (SPAID). We found that whilst disease association
remained highly significant whether the CNV assays
were measured with either qPCR or ddPCR (All assays,
either control group; Mann Whitney p-value < 0.001),
only ddPCR allowed for the true bi-allelic pattern of
inheritance to be followed. In fact, ddPCR also revealed
that whilst CNV pairs were typically inherited in a
predictable manner, e.g. CNV_14.3 = 2 copies with
CNV_16.1 = 10 copies), recombination does occur at this
part of the genome and other combinations of results
are observable, albeit at a much lower frequency. The
continuum of CNV values we observed when using the
qPCR method has also been noted by others using simi-
lar means [28]. It is likely that their ability to resolve
copy number alleles would also improve with ddPCR.
This point is extremely important in the context of gen-
etic testing and future breeding programs.
The reasons as to why ddPCR was able to more clearly
resolve copy number in this setting may simply be due
to the mechanics of that method versus qPCR. For ex-
ample, in our hands and with a subset of 50 samples, we
generated and read approximately 13,000 droplets per
individual tested. Of those accepted droplets, 6,000 on
average contained the VIC labelled reference PCR prod-
uct which equates to 6,000 separate C7orf28b 90 bp
PCR products (Additional file 2: Table S3). This is in
comparison to the four PCR replicates that were mea-
sured for qPCR. The number of FAM droplets is
dependent on the number of 16.1 kb or 14.3 kb seg-
ments and so averaging this value was not appropriate.
There are also differences in the way the two methods
estimate errors and also CNV results, e.g. the normalisa-
tion to a reference individual for the delta delta CT
method of qPCR versus absolute concentration calcula-
tion of ddPCR [21].
However, the differences in copy number results
(Fig. 1b) may also be a reflection of the architecture in
surveyed genome region. It is known that PCR can be
more challenging in GC rich regions, but this does not
seem to be a contributing factor in this case. Both Shar-
Pei copy number elements, and the 100 kb region
encompassing them, are estimated to slightly less than
the average GC content for dog and a set of primates
Table 2 Risk- and odds-ratio test results for the disease associated allele (CNV_16.1, allele 5) and control group C1
Risk Allele SPAID Fever Arthritis Vesicular Hyaluronosis Otitis Amyloidosisa
CNV_16.1|5 Risk 1.31 1.17–1.46 1.33 1.12–1.58 1.32 1.11–1.57 1.33 1.11–1.59 1.39 1.17–1.66 1.04 0.90–1.20
Odds 4.10 2.48–6.74 4.26 2.19–8.30 3.97 1.94–8.11 4.20 1.78–9.89 7.65 2.47–23.71 1.52 0.38–6.09
p-value <0.0001 <0.0001 0.0002 0.0010 0.0001 0.7163
aC3 and not C1 (SPAID negative) allele counts were used for the comparison to the Amyloidosis subphenotype as C1 individuals were not all assessed for the
absence of amyloid deposits in kidney tissues. Fisher two tailed exact probability test was used to calculate significance using allele counts from Table 1
Table 3 The comparison of two classification models of SPAID using alternate control groupsa
Genotypes from marker(s) Control group Tree TP FP Precision Recall F-measure AUC
CNV_14.3 and CNV_16.1 C2 J48 0.715 0.389 0.706 0.715 0.708 0.605
RF 0.715 0.389 0.706 0.715 0.708 0.613
C1 J48 0.810 0.822 0.671 0.810 0.734 0.575
RF 0.810 0.822 0.671 0.810 0.734 0.575
CNV_14.3 C2 J48 0.715 0.389 0.706 0.715 0.708 0.605
RF 0.715 0.389 0.706 0.715 0.708 0.611
C1 J48 0.820 0.820 0.673 0.820 0.739 0.457
RF 0.820 0.820 0.673 0.820 0.739 0.575
CNV_16.1 C2 J48 0.681 0.473 0.661 0.681 0.661 0.599
RF 0.711 0.391 0.702 0.711 0.704 0.612
C1 J48 0.820 0.820 0.673 0.820 0.739 0.457
RF 0.810 0.822 0.671 0.810 0.734 0.580
aTwo control groups were considered. Control 2 (C2, n = 80) contained all dogs free from SPAID, irrespective of age, whilst Control 1 (C1, n = 34) included only
those individuals older than 60 months with no signs of SPAID. The counts required to calculate the receiver operator curve (ROC) area are reported, including
true positive (TP) and false positive (FP)
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(36 % versus 41 % in dog, 43 % in human and 42 % in
chimpanzee and macaque [29]). It seems more likely
that there are complex secondary structure issues that
are resolved when the target genomic DNA is digested
into small five kb blocks as part of the ddPCR protocol.
This may facilitate easier primer binding and product
elongation.
Shar-Pei Autoinflammatory Disease (SPAID) is both a
phenotypically and genetically complex condition [20].
The 16.1 kb CNV is the marker most associated with
disease, explaining 25 % of the genetic heritability in the
studied population, however it is the interplay between
this genomic region and as yet other undiscovered
genes, plus the effect of the dog’s environment, that ul-
timately determines that individual’s clinical disease
status.
In summary, carrying the CNV_16.1|5 allele will in-
crease a dog’s odds of developing disease by four-fold
(Table 2), but this predictive measure does not mean
that the same carrier will present with clinical disease,
be it fever, arthritis, otitis, vesicular hyaluronosis or
amyloidosis. For that reason, we would suggest that the
results of the CNV_16.1 measurement be used to inform
mating strategies, preferentially breeding a homozygous
CNV_16.1|5 individual (i.e. CNV_16.1 = 10 copies) with
either a CNV_16.1 heterozygote (i.e. CNV_16.1 = 6 cop-
ies) or CNV_16.1|1 homozygote (i.e. CNV_16.1 = 2 cop-
ies). However, there appear to be very few CNV_16.1|1
homozygotes (CNV_16.1 = 2 copies) in the general
population; we found only 16 within our tested set of
327 Shar-Pei. Whilst it may seem prudent to use these
individuals widely in order to quickly reduce the number
of homozygous CNV_16.1|5 dogs, this may have dire re-
sults for the breed. The overuse of CNV_16.1|1 homozy-
gotes could serve to reduce the overall genetic diversity
of the breed and perhaps even enrich for as yet un-
known diseases.
Conclusions
These results clearly illustrate the potential for ddPCR
to quantify the true count of alleles at CNVs. This gain
of precision revealed a previously unknown pattern of
allele segregation for two Shar-Pei Specific CNVs and in
doing so allowed for the evaluation of a genetic test. This
test could now be used in carefully managed breeding pro-
grams to methodically reduce the number of individuals
carrying the disease associate allele (CNV_16.1|5) without
dramatically reducing the breed’s overall genetic variation.
Method
SPAID phenotype characterisation
Purebred pet Shar-Pei were sampled from France, the
Netherlands, Sweden and the United States following
owner consent and ethical approvals (See Declaration).
Owners submitted a standardised questionnaire regard-
ing the overall health of their animal. Where possible
they also provided detailed medical records and pedigree
information. This information was compiled, and in con-
junction with veterinarians, used to determine an indi-
vidual’s case or control status. As per Olsson et al. [20],
cases were defined based on the clinical signs of SPAID.
These were, SPAID (S, n = 155): Any one or more of the
five inflammatory signs of SPAID; Fever (F, n =114): Re-
current bouts of fever lasting 6–72 h with no underlying
infection; Arthritis (Ar, n = 79): Recurrent or prolonged
bouts of joint (hock) inflammation with no known
underlying infection; Vesicular Hyaluronosis (V, n = 44):
Dermatological vesicular changes to the skin leading to
recurrent or persistent secondary inflammation; Otitis
(O, n = 34): Recurrent or chronic inflammation of the
ears; Amyloidosis (Am, n = 31): Congo Red stained amyl-
oid deposits observed in a post mortem kidney biopsy.
These categories were not discrete (Additional file 2:
Table S2).
Three control groups were defined. The first, Control
1 (C1, n = 34), encompassed individuals older than
60 months with no signs of SPAID, whilst Control 2
(C2, n = 80) was more relaxed and contained all dogs free
from SPAID, irrespective of age. Control 3 (C3, n = 17)
was specific for the sub-phenotype of Amyloidosis and in-
cluded only those healthy individuals that were negative
for Congo Red stained amyloid deposits in post mortem
kidney tissue and were also free from a clinical history of
unexplained inflammation. Additional pedigree material
(n = 92, Additional file 1: Table S1) was used to test the
stability and transmission of both CNVs assayed.
Genotyping and genetic analysis
Two breed-specific copy number variants were identified
in Olsson et al., [14]. These were termed Traditional
(14.3 kb; CanFam3.1 chr13:20,706,841-20,721,149) and
Meatmouth (16.1 kb; CanFam3.1 chr13: 20,709,024-
20,725,124). To aid clarity, in this manuscript they are
named CNV_14.3 and CNV_16.1 to reflect their length
as opposed to Shar-Pei breed subtypes.
Olsson et al., [14] designed two assay sets (primer pair
and fluorescently labelled probe) that are also utilised in
the current analysis. The first was unique to CNV_16.1,
Assay-CNV-E, and the second acts as a housekeeper for
normalisation, Assay-C7orf28b. Two new assay pairs
were designed for the current work. One set was de-
signed to a unique region of CNV_14.3, Assay-CNV-
East, and the other is an additional set for CNV_16.1,
Assay-CNV-759. All primer and probe assay sets are
listed in Additional file 2: Table S3 and illustrated in
Fig. 1.
We utilised two methodologies, quantitative real-time
PCR (qPCR) and droplet digital PCR (ddPCR) to estimate
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the number of CNV_14.3 and CNV_16.1 copies present
in each DNA sample tested. For qPCR, the (ΔΔCT) rela-
tive quantification method and a reference individual with
known copy number status (German Shepherd 95,
GSP95, Additional file 1: Table S1) was used. The multi-
plex reaction contained a primer limited target copy
number assay for one of the following target assays,
Assay-CNV-East or Assay-CNV-759 or Assay-CNV-E,
plus the housekeeper assay, Assay-C7orf28b. A target
assay comprised 300nM of forward and reverse primer
plus 250nM of FAM labelled probe (LifeTechnologies)
whilst the housekeeper contained 900nM of forward and
reverse primer plus 250nM of VIC labelled probe (Life-
Technologies). These multiplex reactions were performed
in quadruplet using 10 ng of gDNA, Genotyping Mas-
ter Mix (LifeTechnologies) and a 7900HT Real-Time
PCR machine (LifeTechnologies) following manufac-
turers specifications.
For ddPCR, absolute quantification was performed
using 15 ng of DraI (NEB) pre-restriction digested DNA
in a 20ul reaction mix containing 1x ddPCR Supermix
for Probes (BioRad) with 900nM target and reference
primers and 250nM of target and reference probes.
The primers and probes were the same used for qPCR
(Additional file 2: Table S3). The ddPCR reaction mix was
portioned into oil droplets following the manufacturer’s
(BioRad) specifications [30], amplified at 58 °C in a C1000
Touch thermocycler (BioRad) and quantified using a
QX100 instrument (BioRad). QuantaSoft v1.3.1.0 was used
for the visualisation of digital droplet results and for the
calculation of template per droplet based on a Poisson
distribution.
Statistical analysis
In order to assess the utility of either Assay-CNV-E or
Assay-CNV-759 as a diagnostic test for SPAID, we used
the allelic values of each assay as variables and constructed
predictive models using WEKA software [27]. We built
the models using two different statistical-learning algo-
rithms: J48 implementation [27] of Quinlan’s [31] C4.5 de-
cision trees and Breiman’s [26] Random Forest (RF). The
two models were selected to overcome any biases in clas-
sifier choice. RF-based classifiers have proven robust and
reliable on most types of data and as such have become
the primary algorithm of choice. RFs, being an ensemble
method, provide only a limited insight into the actual clas-
sification process in their basic version. This limits our
ability to obtain additional insight into the nature of the
modelled phenomenon. For this reason we also con-
structed an extra set of classifiers using another popular
and robust statistical-learning algorithm, decision trees.
Both types of classifiers were evaluated in a standard 10-
fold cross-validation.
Genome wide association study
Bialellic results from the ddPCR CNV_16.1 assay were
combined with existing Illumina CanineHD array data [20]
for the available 155 SPAID cases and 34 control individ-
uals. GenABEL v1.7-2 [32] in R v2.15.0 was used to per-
form the analysis. Quality control involved tests for missing
genotype calls for single SNP and individuals (<5 %), minor
allele frequency (<0.05) and strong deviations from Hardy-
Weinberg Equilibrium (HWE, p > 1 x10-8). A FDR rate of
0.2 was applied to the controls. From the starting set of
173,663 markers genotyped, 109,966 remained for analysis.
To correct for population stratification, a polygenic mixed
model was fitted which encompassed the Identity-By-State
matrix.
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